Table 3. The comparison of the groups’ clinical findings.
| Group I (CKC) n =30 |
Group II (OKC) n= 28 |
|
|---|---|---|
| VAS 100 (mm) | ||
| Baseline | 72.3 ± 11.4 | 65.6 ± 12.6 |
| 3 months | 41.4 ± 12.9 * | 48.6 ± 11.4 * |
| 6 months | 22.1 ± 10.5 * | 27.2 ± 9.9 * |
| Thigh circumference difference (cm) | ||
| Baseline | 1.1 ± 0.8 | 1.2 ± 0.9 |
| 3 months | 3.2 ± 1.8 * | 4.1 ± 2.1 * |
| 6 months | 1.3 ± 1.5 | 1.6 ± 1.4 |
| Knee flexion (°) | ||
| Baseline | 40.8 ± 17.6 | 45.4 ±16.7 |
| 3 months | 125.6 ± 27.1 * | 110.9 ± 24.1 * |
| 6 months | 135.1 ± 16.1 * | 128.5 ± 18.1 * |
| Lysholm scores | ||
| Baseline | 66.3 ± 12.4 | 64.2 ±10.1 |
| 3 months | 80.8 ± 19.1 | 78.5 ±14.5 |
| 6 months | 94.1 ± 8.5 * | 84.3 ± 9.1 * |
CKC: closed kinetic chain; OKC: open kinetic chain; VAS: Visual Analog Scale. * The intragroup analysis revealed significant improvements after treatment when compared with baseline (p<0.05). Values are presented as mean ± SD.